242 Wythe Ave #4, Brooklyn, NY 11249

Founding year





BiovelocITA S.r.l. is the first Italian accelerator dedicated to biotech. It was founded by Silvano Spinelli, Gabriella Camboni and Sofinnova Partners. Thanks to BiovelocITA, entrepreneurs, scientists and investors can work together to accelerate biotech projects with an international scope and reach the “proof of concept” that precedes the clinical phase. Set up in order to offer innovative solutions to the medical community and patients, BiovelocITA supports the creation and development of innovative biotech companies in all therapeutic areas.

BiovelocITA already has a portfolio of several programs in collaboration with world-class Italian scientists

Enthera, the first spin-off company created to run the diabetes program, is operational from October 2016.